H.R. 3813, CDC Leadership Accountability Act of 2023
As ordered reported by the House Committee on Energy and Commerce on July 19, 2023
By Fiscal Year, Millions of Dollars
2024
2024-2029
2024-2034
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
0
0
0
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2035?
No
Statutory pay-as-you-go procedures apply?
No
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2035?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
H.R. 3813 would accelerate the applicability of the requirement that the Director of the Centers for Disease Control and Prevention be confirmed by the Senate. Under current law, the Senate is required to confirm such appointments made after January 20, 2025. The bill would change that effective date to June 1, 2023. CBO estimates that implementing H.R. 3813 would have no effect on the federal budget.
